Gilead Sciences GILD
NASDAQ GILD
$146.12 +2.68 (+1.87%)
At close: Aug 21, 2026 · 4:00 PM EDT

Gilead Sciences (GILD) Profit After Tax (2009 - 2026)

Gilead Sciences' (GILD) quarterly Profit After Tax came in at $2.0 billion in Q1 2026, up 53.69% YoY from $1.3 billion in Q1 2025, and down 7.42% on a QoQ basis from $2.2 billion in Q4 2025.

Gilead Sciences (GILD) Profit After Tax (2009 - 2026) Analysis & Trends

Gilead Sciences (GILD) has 18 years of Profit After Tax data on file, last reported at $2.0 billion in Q1 2026.

  • Quarterly Profit After Tax rose 53.69% year-over-year to $2.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.2 billion (up 54.5% YoY) and the FY2025 annual result came in at $8.5 billion, up 1672.92% from the prior year.
  • Profit After Tax eased to $2.0 billion in Q1 2026, from $2.2 billion in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $3.1 billion in Q3 2025 to a low of -$4.2 billion in Q1 2024.
  • A 5-year average of $1.2 billion and a median of $1.6 billion in 2024 frame the typical range for Profit After Tax.
  • Annual changes were most pronounced in 2023 — Profit After Tax jumped 5215.79% — and 2024, when it sank 512.87%.
  • Tracing GILD's Profit After Tax over 5 years: stood at $1.6 billion in 2022, then slipped by 13.6% to $1.4 billion in 2023, then rose by 25.83% to $1.8 billion in 2024, then increased by 22.43% to $2.2 billion in 2025, then slipped by 7.42% to $2.0 billion in 2026.
  • The last three Profit After Tax figures came in at $2.0 billion (Q1 2026), $2.2 billion (Q4 2025), and $3.1 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn 5.53 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn 3.62 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn 3.26 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn 2.51 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn 2.38 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn -10.50 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn -248.00 Mn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn 207.96 Mn
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn 438.21 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -10.50 Bn
Mar 31, 2026 2.02 Bn
Dec 31, 2025 2.18 Bn
Sep 30, 2025 3.05 Bn
Jun 30, 2025 1.96 Bn
Mar 31, 2025 1.32 Bn
Dec 31, 2024 1.78 Bn
Sep 30, 2024 1.25 Bn
Jun 30, 2024 1.61 Bn
Mar 31, 2024 -4.17 Bn
Dec 31, 2023 1.42 Bn
Sep 30, 2023 2.17 Bn
Jun 30, 2023 1.04 Bn
Mar 31, 2023 1.01 Bn
Dec 31, 2022 1.64 Bn
Sep 30, 2022 1.79 Bn
Jun 30, 2022 1.14 Bn
Mar 31, 2022 19.00 Mn
Dec 31, 2021 358.00 Mn
Sep 30, 2021 2.59 Bn